A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes
Public ClinicalTrials.gov record NCT03235050. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIb, Randomised, Parallel, Double-Blind Placebo-Controlled and Open-Label Active Comparator Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes Mellitus
Study identification
- NCT ID
- NCT03235050
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 834 participants
Conditions and interventions
Conditions
Interventions
- Liraglutide Drug
- MEDI0382 high dose Drug
- MEDI0382 low dose Drug
- MEDI0382 mid dose Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 1, 2017
- Primary completion
- May 2, 2018
- Completion
- Jun 13, 2019
- Last update posted
- Aug 16, 2020
2017 – 2019
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35205 | — |
| Research Site | Chandler | Arizona | 85224 | — |
| Research Site | Glendale | Arizona | 85306 | — |
| Research Site | Glendale | Arizona | 85308 | — |
| Research Site | Mesa | Arizona | 85213 | — |
| Research Site | Marietta | Georgia | 30067 | — |
| Research Site | Evansville | Indiana | 47715 | — |
| Research Site | Baton Rouge | Louisiana | 70808 | — |
| Research Site | Metairie | Louisiana | 70006 | — |
| Research Site | Elkridge | Maryland | 21075 | — |
| Research Site | Bridgeton | Missouri | 63044 | — |
| Research Site | Las Vegas | Nevada | 89117 | — |
| Research Site | Brooklyn | New York | 11229 | — |
| Research Site | Morehead City | North Carolina | 28557 | — |
| Research Site | Philadelphia | Pennsylvania | 19104 | — |
| Research Site | Greer | South Carolina | 29651 | — |
| Research Site | Houston | Texas | 77040 | — |
| Research Site | Houston | Texas | 77074 | — |
| Research Site | Plano | Texas | 75093 | — |
| Research Site | Layton | Utah | 84014 | — |
| Research Site | Arlington | Virginia | 22206 | — |
| Research Site | Manassas | Virginia | 20110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 97 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03235050, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 16, 2020 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03235050 live on ClinicalTrials.gov.